Humana Inc. (NYSE:HUM) Receives $292.05 Consensus Price Target from Brokerages

Humana Inc. (NYSE:HUM) has been assigned a consensus recommendation of “Hold” from the twenty-two analysts that are covering the company, MarketBeat reports. Five analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $293.3684.

Several research firms have recently weighed in on HUM. Evercore ISI started coverage on Humana in a research report on Monday, September 22nd. They set an “in-line” rating and a $295.00 target price for the company. Guggenheim reaffirmed a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Truist Financial lowered their price objective on shares of Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Mizuho raised their target price on shares of Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Finally, Jefferies Financial Group raised shares of Humana from a “hold” rating to a “buy” rating and lifted their price target for the company from $253.00 to $313.00 in a research note on Friday, December 5th.

Humana Stock Down 3.8%

Shares of NYSE:HUM opened at $273.02 on Thursday. The firm has a market capitalization of $32.84 billion, a PE ratio of 25.59, a price-to-earnings-growth ratio of 2.25 and a beta of 0.45. The business has a 50 day simple moving average of $255.33 and a two-hundred day simple moving average of $263.63. Humana has a 1 year low of $206.87 and a 1 year high of $315.35. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a return on equity of 12.86% and a net margin of 1.02%.The firm had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. During the same period last year, the company earned $4.16 EPS. Humana’s quarterly revenue was up 11.1% compared to the same quarter last year. On average, equities analysts predict that Humana will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.3%. The ex-dividend date is Friday, December 26th. Humana’s payout ratio is 33.18%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. CoreCap Advisors LLC lifted its stake in Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the period. Rosenberg Matthew Hamilton lifted its position in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares during the period. Elevation Point Wealth Partners LLC acquired a new position in Humana during the second quarter valued at $32,000. Mather Group LLC. purchased a new stake in Humana in the third quarter valued at $34,000. Finally, Private Wealth Management Group LLC grew its position in Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 48 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.